US$ 21.84
glp 1 patents Medicines Patent Pool Executive Director Charles Gore tells Devex that one of his priorities in his last year on the job is to get a license for GLP-1 therapies. But he admits How Compounded GLP-1s Are Challenging
Description
GLP-1s (glucagon-like peptide-1 receptor agonists) are a class of medications originally developed to manage type 2 diabetes but now FDA-approved for weight loss in people without diabetes

The therapeutic benefits of GLP-1 RAs have also been reported when used as an adjunct to metformin

Obesity and weight management are often long-term health concerns, and many people find the best results by staying on the medication as a maintenance tool

Overview of Diabetes Treatment [3]